Position in CYTK
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$2,178,478
-$175,365 QoQ
Shares Held
25,572
-28.4% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#213
of 473 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PROFUND ADVISORS LLC holds $162,985,629 across 169 Biotechnology names. CYTK ranks #6 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
23,398 | $11,622,488 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
10,444 | $6,512,251 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
13,814 | $4,158,428 | |
| 4 | MRNA |
Moderna, Inc.
|
33,142 | $2,320,934 | |
| 5 | APGE |
Apogee Therapeutics, Inc.
|
17,163 | $2,278,044 | |
| 6 | CYTK |
Cytokinetics Inc
This page
|
25,572 | $2,178,478 | |
| 7 | KRYS |
Krystal Biotech, Inc.
|
5,770 | $2,144,535 | |
| 8 | KYMR |
Kymera Therapeutics, Inc.
|
18,455 | $2,116,234 |
All Filings in CYTK
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,178,478 | 25,572 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $2,353,843 | 35,713 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $2,518,852 | 39,642 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $1,425,112 | 25,930 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $1,270,321 | 38,448 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $1,367,866 | 34,035 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $1,679,939 | 35,713 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $2,431,545 | 46,052 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $2,813,079 | 51,921 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $1,859,387 | 26,521 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $3,986,564 | 47,749 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,351,595 | 45,879 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,481,991 | 45,432 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $1,410,204 | 40,074 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $259,753 | 5,669 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $302,473 | 6,243 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $226,546 | 5,766 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $252,332 | 6,855 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $345,086 | 7,571 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $284,418 | 7,958 | Shares | Sole | 2021-11-12 | |
| No filing history on record for this holder in this stock. | ||||||